Thomas Ebensen

3.3k total citations
80 papers, 2.4k citations indexed

About

Thomas Ebensen is a scholar working on Immunology, Epidemiology and Microbiology. According to data from OpenAlex, Thomas Ebensen has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 27 papers in Epidemiology and 14 papers in Microbiology. Recurrent topics in Thomas Ebensen's work include Immunotherapy and Immune Responses (32 papers), Immune Response and Inflammation (25 papers) and Immune Cell Function and Interaction (20 papers). Thomas Ebensen is often cited by papers focused on Immunotherapy and Immune Responses (32 papers), Immune Response and Inflammation (25 papers) and Immune Cell Function and Interaction (20 papers). Thomas Ebensen collaborates with scholars based in Germany, Argentina and United States. Thomas Ebensen's co-authors include Carlos A. Guzmán, Kai Schulze, Michael Morr, Claudia Link, Peggy Riese, Tetyana Yevsa, Kenneth C. McCullough, Silvia I. Cazorla, Rebecca Jane Cox and Pablo D. Becker and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas Ebensen

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Ebensen Germany 33 1.3k 692 691 495 268 80 2.4k
Kai Schulze Germany 29 781 0.6× 432 0.6× 567 0.8× 553 1.1× 322 1.2× 71 1.9k
Barbara C. Baudner Italy 25 1.1k 0.9× 617 0.9× 921 1.3× 391 0.8× 151 0.6× 46 2.2k
Pamela A. Kozlowski United States 31 1.8k 1.4× 1.2k 1.7× 617 0.9× 828 1.7× 129 0.5× 76 3.4k
Michael J. McCluskie Canada 33 2.1k 1.7× 1.1k 1.5× 939 1.4× 686 1.4× 140 0.5× 82 3.6k
Anja Seubert Italy 21 1.5k 1.2× 888 1.3× 673 1.0× 556 1.1× 173 0.6× 31 2.5k
Donata Medaglini Italy 30 1.1k 0.9× 455 0.7× 879 1.3× 1.1k 2.1× 207 0.8× 97 2.9k
Reinhard Glück Switzerland 32 1.1k 0.9× 1.3k 1.9× 926 1.3× 666 1.3× 138 0.5× 81 2.8k
Risini D. Weeratna Canada 29 2.6k 2.1× 746 1.1× 1.1k 1.5× 408 0.8× 125 0.5× 58 3.6k
Elly van Riet Netherlands 25 704 0.6× 606 0.9× 506 0.7× 386 0.8× 135 0.5× 40 2.1k
Erik B. Lindblad United States 11 1.0k 0.8× 554 0.8× 576 0.8× 565 1.1× 106 0.4× 14 1.9k

Countries citing papers authored by Thomas Ebensen

Since Specialization
Citations

This map shows the geographic impact of Thomas Ebensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ebensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ebensen more than expected).

Fields of papers citing papers by Thomas Ebensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ebensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ebensen. The network helps show where Thomas Ebensen may publish in the future.

Co-authorship network of co-authors of Thomas Ebensen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ebensen. A scholar is included among the top collaborators of Thomas Ebensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ebensen. Thomas Ebensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebensen, Thomas, et al.. (2024). Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses. Journal of Virology. 98(9). e0035424–e0035424. 4 indexed citations
2.
Méndez, Yanira, Aldrin V. Vasco, Thomas Ebensen, et al.. (2023). Diversification of a Novel α‐Galactosyl Ceramide Hotspot Boosts the Adjuvant Properties in Parenteral and Mucosal Vaccines. Angewandte Chemie. 136(1).
3.
Méndez, Yanira, Aldrin V. Vasco, Thomas Ebensen, et al.. (2023). Diversification of a Novel α‐Galactosyl Ceramide Hotspot Boosts the Adjuvant Properties in Parenteral and Mucosal Vaccines. Angewandte Chemie International Edition. 63(1). e202310983–e202310983. 3 indexed citations
4.
5.
6.
Démoulins, Thomas, Kai Schulze, Thomas Ebensen, et al.. (2023). Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases. Nanomedicine Nanotechnology Biology and Medicine. 49. 102655–102655. 4 indexed citations
7.
Córdoba, Lorena, Edmond J. Remarque, Thomas Ebensen, et al.. (2021). Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF®01 or CDA/αGalCerMPEG. Vaccines. 9(7). 751–751. 7 indexed citations
8.
9.
Müsken, Mathias, et al.. (2019). Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines. Vaccine. 37(35). 4975–4986. 10 indexed citations
10.
Oduro, Jennifer D., Julia D. Boehme, Lisa Borkner, et al.. (2019). Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge. PLoS Pathogens. 15(9). e1008036–e1008036. 26 indexed citations
11.
Trittel, Stephanie, et al.. (2018). Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression. Frontiers in Immunology. 9. 505–505. 45 indexed citations
12.
Schulze, Kai, Thomas Ebensen, Saranya Chandrudu, et al.. (2017). Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2463–2474. 20 indexed citations
13.
Ebensen, Thomas, Kai Schulze, Stephanie Trittel, et al.. (2017). Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway. EBioMedicine. 22. 100–111. 21 indexed citations
14.
Ebensen, Thomas, Jennifer Debarry, Gabriel Kristian Pedersen, et al.. (2017). Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Frontiers in Immunology. 8. 1223–1223. 41 indexed citations
15.
Riese, Peggy, et al.. (2013). Vaccine Adjuvants: Key Tools for Innovative Vaccine Design. Current Topics in Medicinal Chemistry. 13(20). 2562–2580. 51 indexed citations
16.
Ebensen, Thomas & Carlos A. Guzmán. (2008). Immune modulators with defined molecular targets: Cornerstone to optimize rational vaccine design. Human Vaccines. 4(1). 13–22. 20 indexed citations
17.
Ebensen, Thomas, Claudia Link, Peggy Riese, et al.. (2007). A Pegylated Derivative of α-Galactosylceramide Exhibits Improved Biological Properties. The Journal of Immunology. 179(4). 2065–2073. 43 indexed citations
18.
Rharbaoui, Faı̈za, Dunja Bruder, Melita Vidaković, et al.. (2005). Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues. The Journal of Immunology. 174(3). 1317–1324. 18 indexed citations
19.
Borsutzky, Stefan, Thomas Ebensen, Claudia Link, et al.. (2005). Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant. Vaccine. 24(12). 2049–2056. 35 indexed citations
20.
Ebensen, Thomas, Susanne Paukner, Claudia Link, et al.. (2004). Bacterial Ghosts Are an Efficient Delivery System for DNA Vaccines. The Journal of Immunology. 172(11). 6858–6865. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Schulze Breakdown of academic impact, for papers by Barbara C. Baudner Breakdown of academic impact, for papers by Pamela A. Kozlowski Breakdown of academic impact, for papers by Michael J. McCluskie Breakdown of academic impact, for papers by Anja Seubert Breakdown of academic impact, for papers by Donata Medaglini Breakdown of academic impact, for papers by Reinhard Glück Breakdown of academic impact, for papers by Risini D. Weeratna Breakdown of academic impact, for papers by Elly van Riet Breakdown of academic impact, for papers by Erik B. Lindblad
Rankless by CCL
2026